| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/UOG.2686 |
| P698 | PubMed publication ID | 16374755 |
| P2093 | author name string | Nicolaides KH | |
| Tal J | |||
| Cuckle HS | |||
| Turan OM | |||
| Sammar M | |||
| Meiri H | |||
| Bindra R | |||
| Chefetz I | |||
| P433 | issue | 1 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | 13-17 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound | |
| P478 | volume | 27 |
| Q38246351 | A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia |
| Q36189562 | A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia |
| Q34002446 | Adverse pregnancy outcomes after abnormal first-trimester screening for aneuploidy |
| Q35756049 | Biochemical markers for prediction of preclampsia: review of the literature. |
| Q37156676 | Biomarkers for the management of pre-eclampsia in pregnant women. |
| Q90538941 | Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns |
| Q26801503 | Combined Screening for Early Detection of Pre-Eclampsia |
| Q90737682 | Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use |
| Q36951661 | Embryo-placento-maternal interaction and biomarkers: from diagnosis to therapy--a workshop report |
| Q49068373 | Exploring Relationships Among Psychosocial Status, Dietary Quality, and Measures of Placental Development During the First Trimester in Low-Income Women |
| Q37444801 | First-trimester maternal serum PP13 in the risk assessment for preeclampsia. |
| Q35124240 | First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia |
| Q49447471 | Galectin-13, a different prototype galectin, does not bind β-galacto-sides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138. |
| Q28081459 | Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia |
| Q26823092 | Galectins: guardians of eutherian pregnancy at the maternal-fetal interface |
| Q39260574 | Hypertension in pregnancy |
| Q33527649 | Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals |
| Q30402266 | Normal Pregnancy Is Associated with Changes in Central Hemodynamics and Enhanced Recruitable, but Not Resting, Endothelial Function. |
| Q28386182 | Novel biomarkers for predicting preeclampsia |
| Q36065327 | PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia? |
| Q28742192 | PP13, maternal ABO blood groups and the risk assessment of pregnancy complications |
| Q61853964 | PRE-ECLAMPSIA: ONE NAME, TWO CONDITIONS – THE CASE FOR EARLY AND LATE DISEASE BEING DIFFERENT |
| Q58035975 | PROTEOMICS APPROACHES IN PRE-ECLAMPSIA RESEARCH |
| Q42373442 | Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function |
| Q55692173 | Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits. |
| Q26861380 | Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy |
| Q35542826 | Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia |
| Q46328652 | Placental pathology in pregnancy complications |
| Q64112776 | Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration |
| Q37416997 | Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. |
| Q55689583 | Placental protein 13: An important biological protein in preeclampsia. |
| Q36493560 | Placental proteomics: a shortcut to biological insight |
| Q97540484 | Potential Protein Biomarkers for Preeclampsia |
| Q37278804 | Potential markers of preeclampsia--a review |
| Q38227251 | Pre-eclampsia part 2: prediction, prevention and management |
| Q36968505 | Prediction of preeclampsia - a workshop report |
| Q26864872 | Predictive factors for intrauterine growth restriction |
| Q30403325 | Preeclampsia Is Associated with Increased Central Aortic Pressure, Elastic Arteries Stiffness and Wave Reflections, and Resting and Recruitable Endothelial Dysfunction |
| Q91816405 | Protein Misfolding during Pregnancy: New Approaches to Preeclampsia Diagnostics |
| Q58560479 | Resetting the ligand binding site of placental protein 13/galectin-13 recovers its ability to bind lactose |
| Q33783531 | Role of biomarkers in early detection of preeclampsia |
| Q26798011 | Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis |
| Q88490951 | The Critical Role of Abnormal Trophoblast Development in the Etiology of Preeclampsia |
| Q50101341 | The emerging role of galectins in high-fatality cancers |
| Q38561302 | Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions. |
| Q37430265 | Uterine artery pulsatility index in hypertensive pregnancies: When does the index normalize in the puerperium? |
| Q24235562 | Utero-placental Doppler ultrasound for improving pregnancy outcome |
Search more.